IL10 and ulcerative colitis: Takeshita’s study revealed that the prevalence of F.saccharivorans was strikingly lower in active ulcerative colitis than quiescent ones, and suggested that human-derived F.saccharivorans can suppress intestinal inflammation, probably through IL-10 induction (Takeshita et al., 2016).